This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Shuguang Tan: Innovator in Antitumor Research
Introduction
Shuguang Tan is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer research, particularly in the development of targeted therapies. His work focuses on the use of specific T cell receptors to combat tumors associated with KRAS mutations.
Latest Patents
Shuguang Tan holds a patent titled "Screening and Antitumor Use of KRAS Mutation Specific T Cell Receptor." This innovative patent highlights his commitment to advancing cancer treatment options and improving patient outcomes.
Career Highlights
Tan is affiliated with the Chinese Academy of Sciences, where he conducts groundbreaking research. His work has garnered attention for its potential to revolutionize cancer therapies and provide new hope for patients with specific genetic mutations.
Collaborations
Throughout his career, Shuguang Tan has collaborated with notable colleagues, including Fu Gao and Dan Lu. These partnerships have enhanced the scope and impact of his research efforts.
Conclusion
Shuguang Tan's contributions to antitumor research exemplify the importance of innovation in the medical field. His work continues to inspire advancements in cancer treatment and offers hope for future breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile